NCT04879693

Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 250 (estimated)
• Sponsor: DexCom, Inc. · Industry
• Sex: All
• Age: 18 Years – 120 Years
• Healthy volunteers: Not accepted

Summary

Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting

Detailed description

To assess the performance of the CGM System in comparison to a blood glucose comparator method in non-critically ill hospitalized patients who need glucose control.

Conditions

• Patients Needing Glucose Control

Interventions

Type	Name	Description
DEVICE	Continuous Glucose Monitoring System	Continuous Glucose Monitoring System

Timeline

• Start date: 2021-06-01
• Primary completion: 2021-12-01
• Completion: 2021-12-01
• First posted: 2021-05-10
• Last updated: 2021-05-10

Regulatory

• FDA-regulated device study